Showing results (241-250 of 259) with videos related to

Sort By:
Pageof 26
Scientific Reports|January 25, 2017
Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinibArancha Cebrián, Teresa Gómez Del Pulgar, María José Méndez-Vidal, et al.
Nature Communications|February 14, 2025
Morphology of ejecta features from the impact on asteroid DimorphosFabio Ferrari, Paolo Panicucci, Gianmario Merisio, et al.
Medrxiv : the Preprint Server for Health Sciences|January 28, 2026
Comparative impacts and cost-effectiveness of tuberculosis active case-finding strategies in prisons in Brazil, Colombia, and Peru: a mathematical modeling studyYiran E Liu, José Victor Bortolotto Bampi, Ronan F Arthur, et al.
NPJ Breast Cancer|February 8, 2025
Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM studyRegina Peña-Enríquez, Begoña Bermejo, Marina Pollán, et al.
Plos Medicine|June 4, 2026
Comparative impacts and cost-effectiveness of tuberculosis systematic screening strategies in prisons in Brazil, Colombia, and Peru: A mathematical modeling studyYiran E Liu, José Victor Bortolotto Bampi, Ronan F Arthur, et al.
Breast (Edinburgh, Scotland)|November 26, 2020
Palbociclib combined with endocrine therapy in heavily pretreated HR<sup>+</sup>/HER2<sup>-</sup> advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)Luis Manso, Cristina Hernando, María Galán, et al.
Breast Cancer Research : BCR|June 25, 2026
Breastfeeding shapes a unique tumor-immune landscape in pregnancy-associated breast cancer from GEICAM-EMBARCAM studyRegina Peña-Enríquez, Ángel Guerrero-Zotano, Begoña Bermejo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus DocetaxelPriyanka Sharma, Sara López-Tarruella, José Angel García-Saenz, et al.
Breast (Edinburgh, Scotland)|October 7, 2022
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trialJavier Salvador Bofill, Fernando Moreno Anton, Cesar Augusto Rodriguez Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two CohortsPriyanka Sharma, Sara López-Tarruella, Jose Angel García-Saenz, et al.
Pageof 26